APC and Alzheimer disease: To determine whether APC treatment can reverse the amyloid plaques aggravation in AD, the 5xFAD and C57BL/6 WT mice (10 weeks old) were treated with recombinant APC daily (100 μg/kg/d i.p.)or vehicle (saline) for 5 months.